Overexpression of SNORA23 inhibited the proliferation, invasion, and metastasis of HCC cells and knockout of SNORA23 using CRISPR/Cas9-promoted malignant transformation of HCC cells. Here, SNORA23 is linked to hepatocellular carcinoma.